CAS 1185101-22-7

Apafant-d8

Kontrolliertes Produkt

CAS: 1185101-22-7

Applications Platelet activating factor (PAF) antagonist.
References Casals-Stenzel, J., et al.: J. Pharmacol. Exp. Ther., 241, 974 (1987), Adamus, W.S., et al.: Clin. Pharmacol. Ther., 47, 456 (1990), Brecht, H.M., et al.: Arzneim.-Forsch., 41, 51 (1991),

Formel: C₂₂H₁₄D₈ClN₅O₂S

Farbe und Form: Neat

Molekulargewicht: 464.01

Ref: TR-A726102

Apafant-d8

Kontrolliertes Produkt

CAS: 1185101-22-7

Apafant-d8 is an analog of Apafant, a potent inhibitor of the P2Y12 receptor that has been shown to have anticancer activity. This compound inhibits the activity of protein kinases, which play a crucial role in cancer cell proliferation and survival. Apafant-d8 has been tested in Chinese hamster ovary cells and has been found to inhibit the growth of tumor cells in vitro. This compound also has potential as a biomarker for cancer, as it can be detected in urine samples from patients with various types of cancer. Additionally, Apafant-d8 has been shown to have an inhibitory effect on capsaicin-induced apoptosis, suggesting that it may have anti-inflammatory properties as well. Overall, Apafant-d8 is a promising candidate for the development of novel anticancer therapies.

Formel: C₂₂H₂₂ClN₅O₂S

Reinheit: Min. 95%

Molekulargewicht: 456 g/mol

Ref: 3D-KXB10122